Joel Greenblatt Immunome Inc. Transaction History
Gotham Asset Management, LLC
- $16.1 Billion
- Q2 2025
A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Immunome Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 10,200 shares of IMNM stock, worth $170,747. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,200
Previous 10,200
-0.0%
Holding current value
$170,747
Previous $68,000
38.24%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding IMNM
# of Institutions
149Shares Held
66.7MCall Options Held
44.9KPut Options Held
4.24M-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.28MShares$139 Million0.05% of portfolio
-
Redmile Group, LLC San Francisco, CA4.87MShares$81.6 Million5.51% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.69MShares$78.4 Million0.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.52MShares$75.7 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.08MShares$68.3 Million3.27% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $203M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...